N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012  M. Tvede,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A. Bergman, D. Heimer, N. Kondori, H. Enroth 
Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real- time PCR findings in apparently immunocompetent patients: a case.
J.-C. Lagier  Clinical Microbiology and Infection 
I.J. Schalk  Clinical Microbiology and Infection 
C-reactive protein as a marker of infection in critically ill patients
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics  Y.H. van Beurden, S. Nezami,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture  C. Férandon,
R. Cantón  Clinical Microbiology and Infection 
New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Comparison of microscopy, real-time PCR and a rapid immunoassay for the detection of Giardia lamblia in human stool specimens  T. Schuurman, P. Lankamp,
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm  C. Beaulieu, L.-L.
Bacteriophages as a reservoir of extended-spectrum β -lactamase and fluoroquinolone resistance genes in the environment  E. Marti, E. Variatza, J.L. Balcázar 
Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection  Sarah M. Bartsch, Craig A. Umscheid,
Vector control: a cornerstone in the malaria elimination campaign
Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012– 2014: prospective, repeated cross-sectional study  L. Furuya-Kanamori,
Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy  L. Richardson, J. Brite,
Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients  S. Erb, R. Frei,
F. Barbut, L. Surgers, C. Eckert, B. Visseaux, M. Cuingnet, C
Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients.
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar 
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study  E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.
L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C
Mathematical modeling of Clostridium difficile infection
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection  M.J.T.
Detection of Wolbachia genes in a patient with non-Hodgkin's lymphoma
R. Alonso, C. Muñoz, T. Peláez, E. Cercenado, M. Rodríguez-Creixems, E
Interference between respiratory syncytial virus and rhinovirus in respiratory tract infections in children  S. Karppinen, L. Toivonen, L. Schuez-Havupalo,
Systematic review of antibiotic consumption in acute care hospitals
Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia—a post hoc analysis in 964 prospectively evaluated patients  S. Rieg,
Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples  J. Stahlmann,
Y. Huang, B. Yang, W. Li  Clinical Microbiology and Infection 
Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk.
How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex.
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Statin use and clinical outcomes among pneumonia patients
Microbiologic factors affecting Clostridium difficile recurrence
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
Real-time comparative monitoring of the A/H1N1 pandemic in France
C.P. Kelly  Clinical Microbiology and Infection 
Clostridium difficile toxin testing by National Health Service (NHS) acute Trusts in England: 2008–2013  S.M. Gerver, A.P. Johnson, R.J. Hope  Clinical.
Survival of rhinoviruses on human fingers
Virology: a scientific discipline facing new challenges
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe 
Quantitative real-time PCR and the (1 → 3)-β-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization  Y. Matsumura,
Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain  J.-Y. Wang, H.-L.
J.L. Balcázar  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
A. Vankeerberghen, S. Jonckheere, H. De Raeve, R. Caluwe, H
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection  A. Russo, M. Falcone, M. Fantoni, R. Murri,
Presentation transcript:

PCR cycle threshold value predicts the course of Clostridium difficile infection  N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch  Clinical Microbiology and Infection  Volume 22, Issue 2, Pages e7-e8 (February 2016) DOI: 10.1016/j.cmi.2015.09.012 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 (a) Comparison of the Clostridium difficile PCR cycle thresholds of stool samples from patients in the different clinical groups. The horizontal line in each box indicates the median; whereas the top and bottom lines represent the 75th and 25th centiles, respectively. The ‘whiskers’ extend to the minimum and maximum value per group. *Cycle threshold (CT) values of patients with severe disease were significantly lower compared with patients of the other four groups (p 0.02). (CDI, Clostridium difficile infection; TC, toxigenic culture). (b) The area under the receiver operating characteristic (ROC) curve for toxin B cycle threshold as a predictor for severe disease was significantly increased (area under ROC curve: 0.77 (95% CI 0.62–0.92, p 0.013). Clinical Microbiology and Infection 2016 22, e7-e8DOI: (10.1016/j.cmi.2015.09.012) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions